MEDISIEVE

Updated 797 days ago
Private Limited Company
  • Active - 08983823 (CH)
  • Age: 10 years
  • ID: 52346051/6
48 Chancery Lane, London, WC2A 1JF
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
• 72190 - Other research and experimental development on natural sciences and engineering
A spin-out from University College London, MediSieve is a multi-award-winning company dedicated to the development and commercialisation of MBF. The company has raised a total of £4M in equity funding and won grants worth a total of over £4M from the Wellcome Trust, Innovate UK, NIHR i4i and the EU Horizon 2020 SME Instrument. We closed a £1.8M Series A in May 2021, and in December 2020 secured a £1.6M grant from the UKRI to support clinical trials, which are due to start in 2021... Our multidisciplinary team has experience across various fields of science and technology development... MediSieve's first product targets IL-6 cytokine to treat various hyperinflammation condition like Sepsis, COVID-19, and Cytokine Release Syndrome.
Also known as: MEDISIEVE LTD
Registration numbers: 08983823 (CH), 8983823 (W)
Primary location: London United Kingdom
  • 0
  • 0
Interest Score
1
HIT Score
0.00
CEO
Dr George Frodsham
CTO
Dr Cristina Blanco-Andujar
Founder
Dr George Frodsham
General
in..@medisieve.co.uk, in..@medisieve.co.uk

UK Company Data

Company number
08983823		 Account category
TOTAL EXEMPTION FULL		 Account ref. day
30		 Account ref. month
9
Accounts next due date
2025-06-30		 Accounts last made up date
2023-09-30		 Returns next due date
2017-05-06		 Returns last made up date
2016-04-08
Num. mort. charges
1		 Num. mort. outstanding
1		 Num. mort. part. satisfied
0		 Num. mort. satisfied
0
Num. gen. partners
0		 Num. lim. partners
0
Domain
medisieve.co.uk
Actual
www.medisieve.com
IP
3.33.152.147, 15.197.142.173
Status
OK
Category
Company, Other
0 comments Add a comment